Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

The plant pathogen in Australia evolves through existing genetic variation, not new genotypes.

Gabapentin may help relieve itchy scalp in lichen planopilaris patients.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Forensic medicine is crucial for justice and needs continuous innovation and technology integration.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

ADSC-enriched fat grafting is the best and safest aesthetic treatment, combining effectiveness and ethical confidence.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Higher blood sugar levels may lead to more severe hair loss in women.

Low-dose spironolactone can be effective for treating hair loss in women.

Patients were highly satisfied with shared medical appointments for hair loss treatment.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Platelet-rich plasma may help with hair loss from androgenetic alopecia.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Lentiginous melanoma is most common on the face, especially the nose, cheek, and pre-auricular areas, with men more likely to have it on the scalp, ears, upper back, and trapezius, and women on the cheek and anterior arm. Sun damage is a key factor in its formation.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

New treatments for hair-pulling disorder focus on personalized approaches and combining therapies for better results.

Activin A promotes ear hair cell development, while follistatin delays it.

BRG1 is essential for skin cells to move and heal wounds properly.